Administration of end-of-life drugs by family caregivers during Covid-19 pandemic

Article indépendant

BOWERS, Ben | POLLOCK, Kristian | BARCLAY, Stephen

Doctors, nurses, and family caregivers worldwide are facing tough decisions concerning the supply and administration of medications to manage symptoms when patients are dying from covid-19 or other conditions in the community or care homes. Proposed changes in practice aimed at ensuring adequate end-of-life symptom control need careful consideration alongside appropriate training and support. Updated UK advice, including NICE rapid guidance on managing covid-19 symptoms in the community, reiterates the importance of prescribing medications in advance of need for pain, nausea and vomiting, agitation, and respiratory secretions. These drugs may be administered if needed by visiting doctors or nurses, as is already well established in some countries. However, this practice is being overhauled radically in response to the pandemic. [Premiers paragraphes]

http://dx.doi.org/10.1136/bmj.m1615

Voir la revue «BMJ, 369»

Autres numéros de la revue «BMJ»

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Gestion